Source:http://linkedlifedata.com/resource/pubmed/id/16920066
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0012634,
umls-concept:C0017262,
umls-concept:C0035647,
umls-concept:C0086022,
umls-concept:C0087111,
umls-concept:C0185117,
umls-concept:C0332298,
umls-concept:C0334094,
umls-concept:C0336791,
umls-concept:C0442335,
umls-concept:C1506928,
umls-concept:C1705099,
umls-concept:C1705438,
umls-concept:C2603343,
umls-concept:C2911684
|
pubmed:issue |
4
|
pubmed:dateCreated |
2006-8-30
|
pubmed:abstractText |
We have constructed a lentiviral vector with expression limited to cells presenting active E2F-1 protein, a potential advantage for gene therapy of proliferative diseases. For the FE2FLW vector, the promoter region of the human E2F-1 gene was utilized to drive expression of luciferase cDNA, included as a reporter of viral expression. Primary, immortalized, and transformed cells were transduced with the FE2FLW vector and cell cycle alterations were induced with serum starvation/replacement, contact inhibition or drug treatment, revealing cell cycle-dependent changes in reporter activity. Forced E2F-1 expression, but not E2F-2 or E2F-3, increased reporter activity, indicating a major role for this factor in controlling expression from the FE2FLW virus. We show the utility of this vector as a reporter of E2F-1 and proliferation-dependent cellular alterations upon cytotoxic/cytostatic treatment, such as the introduction of tumor suppressor genes. We propose that the FE2FLW vector may be a starting point for the development of gene therapy strategies for proliferative diseases, such as cancer or restinosis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0006-291X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
6
|
pubmed:volume |
348
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1411-8
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:16920066-Animals,
pubmed-meshheading:16920066-Cell Cycle,
pubmed-meshheading:16920066-Cell Proliferation,
pubmed-meshheading:16920066-Cells, Cultured,
pubmed-meshheading:16920066-E2F Transcription Factors,
pubmed-meshheading:16920066-E2F1 Transcription Factor,
pubmed-meshheading:16920066-Gene Expression Regulation,
pubmed-meshheading:16920066-Gene Therapy,
pubmed-meshheading:16920066-Genes, Reporter,
pubmed-meshheading:16920066-Genes, Tumor Suppressor,
pubmed-meshheading:16920066-Genetic Vectors,
pubmed-meshheading:16920066-Humans,
pubmed-meshheading:16920066-Lentivirus,
pubmed-meshheading:16920066-Promoter Regions, Genetic,
pubmed-meshheading:16920066-Rats
|
pubmed:year |
2006
|
pubmed:articleTitle |
A lentiviral vector with expression controlled by E2F-1: a potential tool for the study and treatment of proliferative diseases.
|
pubmed:affiliation |
Viral Vector Group, Laboratory of Genetics and Molecular Cardiology/LIM-13, University of São Paulo School of Medicine, Brazil. bstrauss@usp.br
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|